This report aims to provide a comprehensive presentation of the global market for Living Biological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Living Biological Drugs. This report contains market size and forecasts of Living Biological Drugs in global, including the following market information:
Global Living Biological Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Living Biological Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Single Strain Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Living Biological Drugs include Ardeypharman, Miyarisan Pharmaceutical, Ferring Pharmaceuticals, Seres Therapeutics, Infant Bacterial Therapeutics, Osel, Takeda, AOBiome and Synlogic, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Living Biological Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Living Biological Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Living Biological Drugs Market Segment Percentages, by Type, 2022 (%)
Single Strain
Multi Strain
Co-Culture
Global Living Biological Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Living Biological Drugs Market Segment Percentages, by Application, 2022 (%)
Digestive System
Urinary System
Skin System
Global Living Biological Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Living Biological Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Living Biological Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Living Biological Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ardeypharman
Miyarisan Pharmaceutical
Ferring Pharmaceuticals
Seres Therapeutics
Infant Bacterial Therapeutics
Osel
Takeda
AOBiome
Synlogic
Finch Therapeutics
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
Luina Bio
List Labs
MatriSys Bioscience
Outline of Major Chapters:
Chapter 1: Introduces the definition of Living Biological Drugs, market overview.
Chapter 2: Global Living Biological Drugs market size in revenue.
Chapter 3: Detailed analysis of Living Biological Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Living Biological Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Living Biological Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Living Biological Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Living Biological Drugs Overall Market Size
2.1 Global Living Biological Drugs Market Size: 2022 VS 2029
2.2 Global Living Biological Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Living Biological Drugs Players in Global Market
3.2 Top Global Living Biological Drugs Companies Ranked by Revenue
3.3 Global Living Biological Drugs Revenue by Companies
3.4 Top 3 and Top 5 Living Biological Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Living Biological Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Living Biological Drugs Players in Global Market
3.6.1 List of Global Tier 1 Living Biological Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Living Biological Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Living Biological Drugs Market Size Markets, 2022 & 2029
4.1.2 Single Strain
4.1.3 Multi Strain
4.1.4 Co-Culture
4.2 By Type - Global Living Biological Drugs Revenue & Forecasts
4.2.1 By Type - Global Living Biological Drugs Revenue, 2018-2023
4.2.2 By Type - Global Living Biological Drugs Revenue, 2024-2029
4.2.3 By Type - Global Living Biological Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Living Biological Drugs Market Size, 2022 & 2029
5.1.2 Digestive System
5.1.3 Urinary System
5.1.4 Skin System
5.2 By Application - Global Living Biological Drugs Revenue & Forecasts
5.2.1 By Application - Global Living Biological Drugs Revenue, 2018-2023
5.2.2 By Application - Global Living Biological Drugs Revenue, 2024-2029
5.2.3 By Application - Global Living Biological Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Living Biological Drugs Market Size, 2022 & 2029
6.2 By Region - Global Living Biological Drugs Revenue & Forecasts
6.2.1 By Region - Global Living Biological Drugs Revenue, 2018-2023
6.2.2 By Region - Global Living Biological Drugs Revenue, 2024-2029
6.2.3 By Region - Global Living Biological Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Living Biological Drugs Revenue, 2018-2029
6.3.2 US Living Biological Drugs Market Size, 2018-2029
6.3.3 Canada Living Biological Drugs Market Size, 2018-2029
6.3.4 Mexico Living Biological Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Living Biological Drugs Revenue, 2018-2029
6.4.2 Germany Living Biological Drugs Market Size, 2018-2029
6.4.3 France Living Biological Drugs Market Size, 2018-2029
6.4.4 U.K. Living Biological Drugs Market Size, 2018-2029
6.4.5 Italy Living Biological Drugs Market Size, 2018-2029
6.4.6 Russia Living Biological Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Living Biological Drugs Market Size, 2018-2029
6.4.8 Benelux Living Biological Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Living Biological Drugs Revenue, 2018-2029
6.5.2 China Living Biological Drugs Market Size, 2018-2029
6.5.3 Japan Living Biological Drugs Market Size, 2018-2029
6.5.4 South Korea Living Biological Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Living Biological Drugs Market Size, 2018-2029
6.5.6 India Living Biological Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Living Biological Drugs Revenue, 2018-2029
6.6.2 Brazil Living Biological Drugs Market Size, 2018-2029
6.6.3 Argentina Living Biological Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Living Biological Drugs Revenue, 2018-2029
6.7.2 Turkey Living Biological Drugs Market Size, 2018-2029
6.7.3 Israel Living Biological Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Living Biological Drugs Market Size, 2018-2029
6.7.5 UAE Living Biological Drugs Market Size, 2018-2029
7 Living Biological Drugs Companies Profiles
7.1 Ardeypharman
7.1.1 Ardeypharman Company Summary
7.1.2 Ardeypharman Business Overview
7.1.3 Ardeypharman Living Biological Drugs Major Product Offerings
7.1.4 Ardeypharman Living Biological Drugs Revenue in Global Market (2018-2023)
7.1.5 Ardeypharman Key News & Latest Developments
7.2 Miyarisan Pharmaceutical
7.2.1 Miyarisan Pharmaceutical Company Summary
7.2.2 Miyarisan Pharmaceutical Business Overview
7.2.3 Miyarisan Pharmaceutical Living Biological Drugs Major Product Offerings
7.2.4 Miyarisan Pharmaceutical Living Biological Drugs Revenue in Global Market (2018-2023)
7.2.5 Miyarisan Pharmaceutical Key News & Latest Developments
7.3 Ferring Pharmaceuticals
7.3.1 Ferring Pharmaceuticals Company Summary
7.3.2 Ferring Pharmaceuticals Business Overview
7.3.3 Ferring Pharmaceuticals Living Biological Drugs Major Product Offerings
7.3.4 Ferring Pharmaceuticals Living Biological Drugs Revenue in Global Market (2018-2023)
7.3.5 Ferring Pharmaceuticals Key News & Latest Developments
7.4 Seres Therapeutics
7.4.1 Seres Therapeutics Company Summary
7.4.2 Seres Therapeutics Business Overview
7.4.3 Seres Therapeutics Living Biological Drugs Major Product Offerings
7.4.4 Seres Therapeutics Living Biological Drugs Revenue in Global Market (2018-2023)
7.4.5 Seres Therapeutics Key News & Latest Developments
7.5 Infant Bacterial Therapeutics
7.5.1 Infant Bacterial Therapeutics Company Summary
7.5.2 Infant Bacterial Therapeutics Business Overview
7.5.3 Infant Bacterial Therapeutics Living Biological Drugs Major Product Offerings
7.5.4 Infant Bacterial Therapeutics Living Biological Drugs Revenue in Global Market (2018-2023)
7.5.5 Infant Bacterial Therapeutics Key News & Latest Developments
7.6 Osel
7.6.1 Osel Company Summary
7.6.2 Osel Business Overview
7.6.3 Osel Living Biological Drugs Major Product Offerings
7.6.4 Osel Living Biological Drugs Revenue in Global Market (2018-2023)
7.6.5 Osel Key News & Latest Developments
7.7 Takeda
7.7.1 Takeda Company Summary
7.7.2 Takeda Business Overview
7.7.3 Takeda Living Biological Drugs Major Product Offerings
7.7.4 Takeda Living Biological Drugs Revenue in Global Market (2018-2023)
7.7.5 Takeda Key News & Latest Developments
7.8 AOBiome
7.8.1 AOBiome Company Summary
7.8.2 AOBiome Business Overview
7.8.3 AOBiome Living Biological Drugs Major Product Offerings
7.8.4 AOBiome Living Biological Drugs Revenue in Global Market (2018-2023)
7.8.5 AOBiome Key News & Latest Developments
7.9 Synlogic
7.9.1 Synlogic Company Summary
7.9.2 Synlogic Business Overview
7.9.3 Synlogic Living Biological Drugs Major Product Offerings
7.9.4 Synlogic Living Biological Drugs Revenue in Global Market (2018-2023)
7.9.5 Synlogic Key News & Latest Developments
7.10 Finch Therapeutics
7.10.1 Finch Therapeutics Company Summary
7.10.2 Finch Therapeutics Business Overview
7.10.3 Finch Therapeutics Living Biological Drugs Major Product Offerings
7.10.4 Finch Therapeutics Living Biological Drugs Revenue in Global Market (2018-2023)
7.10.5 Finch Therapeutics Key News & Latest Developments
7.11 Capsugel
7.11.1 Capsugel Company Summary
7.11.2 Capsugel Business Overview
7.11.3 Capsugel Living Biological Drugs Major Product Offerings
7.11.4 Capsugel Living Biological Drugs Revenue in Global Market (2018-2023)
7.11.5 Capsugel Key News & Latest Developments
7.12 Jeneil Biotech
7.12.1 Jeneil Biotech Company Summary
7.12.2 Jeneil Biotech Business Overview
7.12.3 Jeneil Biotech Living Biological Drugs Major Product Offerings
7.12.4 Jeneil Biotech Living Biological Drugs Revenue in Global Market (2018-2023)
7.12.5 Jeneil Biotech Key News & Latest Developments
7.13 UAS Labs
7.13.1 UAS Labs Company Summary
7.13.2 UAS Labs Business Overview
7.13.3 UAS Labs Living Biological Drugs Major Product Offerings
7.13.4 UAS Labs Living Biological Drugs Revenue in Global Market (2018-2023)
7.13.5 UAS Labs Key News & Latest Developments
7.14 Biose
7.14.1 Biose Company Summary
7.14.2 Biose Business Overview
7.14.3 Biose Living Biological Drugs Major Product Offerings
7.14.4 Biose Living Biological Drugs Revenue in Global Market (2018-2023)
7.14.5 Biose Key News & Latest Developments
7.15 Cerbios-Pharma
7.15.1 Cerbios-Pharma Company Summary
7.15.2 Cerbios-Pharma Business Overview
7.15.3 Cerbios-Pharma Living Biological Drugs Major Product Offerings
7.15.4 Cerbios-Pharma Living Biological Drugs Revenue in Global Market (2018-2023)
7.15.5 Cerbios-Pharma Key News & Latest Developments
7.16 Inpac Probiotics
7.16.1 Inpac Probiotics Company Summary
7.16.2 Inpac Probiotics Business Overview
7.16.3 Inpac Probiotics Living Biological Drugs Major Product Offerings
7.16.4 Inpac Probiotics Living Biological Drugs Revenue in Global Market (2018-2023)
7.16.5 Inpac Probiotics Key News & Latest Developments
7.17 NIZO
7.17.1 NIZO Company Summary
7.17.2 NIZO Business Overview
7.17.3 NIZO Living Biological Drugs Major Product Offerings
7.17.4 NIZO Living Biological Drugs Revenue in Global Market (2018-2023)
7.17.5 NIZO Key News & Latest Developments
7.18 Winclove Probiotics
7.18.1 Winclove Probiotics Company Summary
7.18.2 Winclove Probiotics Business Overview
7.18.3 Winclove Probiotics Living Biological Drugs Major Product Offerings
7.18.4 Winclove Probiotics Living Biological Drugs Revenue in Global Market (2018-2023)
7.18.5 Winclove Probiotics Key News & Latest Developments
7.19 BJP Laboratories
7.19.1 BJP Laboratories Company Summary
7.19.2 BJP Laboratories Business Overview
7.19.3 BJP Laboratories Living Biological Drugs Major Product Offerings
7.19.4 BJP Laboratories Living Biological Drugs Revenue in Global Market (2018-2023)
7.19.5 BJP Laboratories Key News & Latest Developments
7.20 Luina Bio
7.20.1 Luina Bio Company Summary
7.20.2 Luina Bio Business Overview
7.20.3 Luina Bio Living Biological Drugs Major Product Offerings
7.20.4 Luina Bio Living Biological Drugs Revenue in Global Market (2018-2023)
7.20.5 Luina Bio Key News & Latest Developments
7.21 List Labs
7.21.1 List Labs Company Summary
7.21.2 List Labs Business Overview
7.21.3 List Labs Living Biological Drugs Major Product Offerings
7.21.4 List Labs Living Biological Drugs Revenue in Global Market (2018-2023)
7.21.5 List Labs Key News & Latest Developments
7.22 MatriSys Bioscience
7.22.1 MatriSys Bioscience Company Summary
7.22.2 MatriSys Bioscience Business Overview
7.22.3 MatriSys Bioscience Living Biological Drugs Major Product Offerings
7.22.4 MatriSys Bioscience Living Biological Drugs Revenue in Global Market (2018-2023)
7.22.5 MatriSys Bioscience Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Living Biological Drugs Market Opportunities & Trends in Global Market
Table 2. Living Biological Drugs Market Drivers in Global Market
Table 3. Living Biological Drugs Market Restraints in Global Market
Table 4. Key Players of Living Biological Drugs in Global Market
Table 5. Top Living Biological Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Living Biological Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Living Biological Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Living Biological Drugs Product Type
Table 9. List of Global Tier 1 Living Biological Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Living Biological Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Living Biological Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Living Biological Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Living Biological Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Living Biological Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Living Biological Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Living Biological Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Living Biological Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Living Biological Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Living Biological Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Living Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Living Biological Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Living Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Living Biological Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Living Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Living Biological Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Living Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Living Biological Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Living Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Living Biological Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Ardeypharman Company Summary
Table 31. Ardeypharman Living Biological Drugs Product Offerings
Table 32. Ardeypharman Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Ardeypharman Key News & Latest Developments
Table 34. Miyarisan Pharmaceutical Company Summary
Table 35. Miyarisan Pharmaceutical Living Biological Drugs Product Offerings
Table 36. Miyarisan Pharmaceutical Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Miyarisan Pharmaceutical Key News & Latest Developments
Table 38. Ferring Pharmaceuticals Company Summary
Table 39. Ferring Pharmaceuticals Living Biological Drugs Product Offerings
Table 40. Ferring Pharmaceuticals Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Ferring Pharmaceuticals Key News & Latest Developments
Table 42. Seres Therapeutics Company Summary
Table 43. Seres Therapeutics Living Biological Drugs Product Offerings
Table 44. Seres Therapeutics Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Seres Therapeutics Key News & Latest Developments
Table 46. Infant Bacterial Therapeutics Company Summary
Table 47. Infant Bacterial Therapeutics Living Biological Drugs Product Offerings
Table 48. Infant Bacterial Therapeutics Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Infant Bacterial Therapeutics Key News & Latest Developments
Table 50. Osel Company Summary
Table 51. Osel Living Biological Drugs Product Offerings
Table 52. Osel Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Osel Key News & Latest Developments
Table 54. Takeda Company Summary
Table 55. Takeda Living Biological Drugs Product Offerings
Table 56. Takeda Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Takeda Key News & Latest Developments
Table 58. AOBiome Company Summary
Table 59. AOBiome Living Biological Drugs Product Offerings
Table 60. AOBiome Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. AOBiome Key News & Latest Developments
Table 62. Synlogic Company Summary
Table 63. Synlogic Living Biological Drugs Product Offerings
Table 64. Synlogic Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Synlogic Key News & Latest Developments
Table 66. Finch Therapeutics Company Summary
Table 67. Finch Therapeutics Living Biological Drugs Product Offerings
Table 68. Finch Therapeutics Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Finch Therapeutics Key News & Latest Developments
Table 70. Capsugel Company Summary
Table 71. Capsugel Living Biological Drugs Product Offerings
Table 72. Capsugel Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Capsugel Key News & Latest Developments
Table 74. Jeneil Biotech Company Summary
Table 75. Jeneil Biotech Living Biological Drugs Product Offerings
Table 76. Jeneil Biotech Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Jeneil Biotech Key News & Latest Developments
Table 78. UAS Labs Company Summary
Table 79. UAS Labs Living Biological Drugs Product Offerings
Table 80. UAS Labs Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. UAS Labs Key News & Latest Developments
Table 82. Biose Company Summary
Table 83. Biose Living Biological Drugs Product Offerings
Table 84. Biose Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Biose Key News & Latest Developments
Table 86. Cerbios-Pharma Company Summary
Table 87. Cerbios-Pharma Living Biological Drugs Product Offerings
Table 88. Cerbios-Pharma Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Cerbios-Pharma Key News & Latest Developments
Table 90. Inpac Probiotics Company Summary
Table 91. Inpac Probiotics Living Biological Drugs Product Offerings
Table 92. Inpac Probiotics Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Inpac Probiotics Key News & Latest Developments
Table 94. NIZO Company Summary
Table 95. NIZO Living Biological Drugs Product Offerings
Table 96. NIZO Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. NIZO Key News & Latest Developments
Table 98. Winclove Probiotics Company Summary
Table 99. Winclove Probiotics Living Biological Drugs Product Offerings
Table 100. Winclove Probiotics Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Winclove Probiotics Key News & Latest Developments
Table 102. BJP Laboratories Company Summary
Table 103. BJP Laboratories Living Biological Drugs Product Offerings
Table 104. BJP Laboratories Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. BJP Laboratories Key News & Latest Developments
Table 106. Luina Bio Company Summary
Table 107. Luina Bio Living Biological Drugs Product Offerings
Table 108. Luina Bio Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 109. Luina Bio Key News & Latest Developments
Table 110. List Labs Company Summary
Table 111. List Labs Living Biological Drugs Product Offerings
Table 112. List Labs Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 113. List Labs Key News & Latest Developments
Table 114. MatriSys Bioscience Company Summary
Table 115. MatriSys Bioscience Living Biological Drugs Product Offerings
Table 116. MatriSys Bioscience Living Biological Drugs Revenue (US$, Mn) & (2018-2023)
Table 117. MatriSys Bioscience Key News & Latest Developments
List of Figures
Figure 1. Living Biological Drugs Segment by Type in 2022
Figure 2. Living Biological Drugs Segment by Application in 2022
Figure 3. Global Living Biological Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Living Biological Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Living Biological Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Living Biological Drugs Revenue in 2022
Figure 8. By Type - Global Living Biological Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Living Biological Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Living Biological Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Living Biological Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Living Biological Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Living Biological Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Living Biological Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Living Biological Drugs Revenue Market Share, 2018-2029
Figure 16. US Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Living Biological Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Living Biological Drugs Revenue Market Share, 2018-2029
Figure 28. China Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Living Biological Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Living Biological Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Living Biological Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Ardeypharman Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Miyarisan Pharmaceutical Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ferring Pharmaceuticals Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Seres Therapeutics Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Infant Bacterial Therapeutics Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Osel Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Takeda Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AOBiome Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Synlogic Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Finch Therapeutics Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Capsugel Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Jeneil Biotech Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. UAS Labs Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Biose Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Cerbios-Pharma Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Inpac Probiotics Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. NIZO Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Winclove Probiotics Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. BJP Laboratories Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Luina Bio Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. List Labs Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. MatriSys Bioscience Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
